The novel therapy of this peptide represents a major advance in the handling of diabetes mellitus type 2. Different to existing medications, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide930044.ssnblog.com/40585013/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment